Khairy: Malaysia, Merck sign agreement for Covid-19 drug Molnupiravir

By Joseph Kaos Jr

PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

Health Minister Khairy Jamaluddin said the government signed a letter of undertaking on Thursday (Oct 7) to procure 150,000 courses of Molnupiravir to treat Covid-19 patients.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Subscribe

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Subscribe

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only

Subscribe
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Covid-19 , Malaysia , Merck , Khairy Jamaluddin , Molnupiravir , Covid-19 drug , Health Minister , Health Ministry

   

Report it to us.

Next In Nation
Machete-wielding robbers from Muar arrested in Sungkai, remanded seven days
Johor govt allocated more than RM10mil to support state healthcare system this year, says exco rep
Man dies trapped under car after Kota Baru accident
Partial power outage fully restored, says Sarawak Energy
Dead cats at UM: Thorough probe needed, says Dr Wan Azizah
Colourful decor, year-end promos draw crowds ahead of Christmas in KL
SAR operation for two missing fishermen in Kuala Sungai Pinang called off
Sabah Pakatan Youth backs Ewon's selection as state chairman
Video alleging durian land allocation is actually STR land rights handover, says Pahang exco rep
Low pressure system off Sarawak could turn into tropical depression, MetMalaysia warns

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.